TREAT-NMD is a network for the neuromuscular field that provides an infrastructure to ensure that the most promising new therapies reach patients as quickly as possible. Since its launch in January 2007 the network’s focus has been on the development of tools that industry, clinicians and scientists need to bring novel therapeutic approaches through preclinical development into the clinic, and on establishing best-practice care for neuromuscular patients worldwide.

TREAT-NMD is the scientific coordinator of Project PaLaDIn, and its market-defining Global Registries Platform is underpinning the entire project. TREAT-NMD is leading WP5, and co-leading WP1. TREAT-NMD is also a Contributing Partner, providing approximately €5m of in-kind contribution to operational activities (IKOP) to the consortium.